CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...